Cargando…

The value of tumour markers in lung cancer.

The pre-treatment serum levels of neuron-specific enolase (NSE), phosphohexose isomerase (PHI) and circulating immune complexes (CC) as tumour markers were compared to measurements of standard haematology and biochemical indices in 73 patients with lung cancer, as an aid to differentiation of tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomm, S. A., Keevil, B. G., Thatcher, N., Hasleton, P. S., Swindell, R. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246882/ https://www.ncbi.nlm.nih.gov/pubmed/2906254

Ejemplares similares

Pulmonary carcinoid tumours: a clinico-pathological study of 35 cases.
por: Hasleton, P. S., et al.
Publicado: (1986)

Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival.
por: Dazzi, H., et al.
Publicado: (1989)

Genetic predisposition to human lung cancer.
por: Heighway, J., et al.
Publicado: (1986)

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody.
por: Dazzi, H., et al.
Publicado: (1990)

Blood groups and lung cancer.
por: Roberts, T. E., et al.
Publicado: (1988)

Expression of epidermal growth factor receptor (EGF-R) in human lung tumours.
por: Cerny, T., et al.
Publicado: (1986)

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.
por: Betticher, D. C., et al.
Publicado: (1997)

A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
por: Cerny, T., et al.
Publicado: (1989)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
por: Gomm, S. A., et al.
Publicado: (1991)

Immunoreactivity of various peptides in typical and atypical bronchopulmonary carcinoid tumours.
por: al-Saffar, N., et al.
Publicado: (1988)

c-Ki-ras amplification in human lung cancer.
por: Heighway, J., et al.
Publicado: (1986)

Tumour cords in 52 human bronchial and cervical squamous cell carcinomas: inferences for their cellular kinetics and radiobiology.
por: Moore, J. V., et al.
Publicado: (1985)

Comparative values of several tumour markers: example of untreated breast carcinoma.
por: Cazin, J. L., et al.
Publicado: (1990)

The value of lactate dehydrogenase as a nonspecific tumour marker for seminoma of the testis.
por: Robertson, A. G., et al.
Publicado: (1982)

Salivary androgens in adolescence and their value as a marker of puberty: results from the SCAMP cohort
por: Patjamontri, Supitcha, et al.
Publicado: (2023)

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
por: Johnson, P. W., et al.
Publicado: (1993)

Tumour markers in breast cancer.
por: Cove, D. H., et al.
Publicado: (1979)

Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours.
por: Chander, S. K., et al.
Publicado: (1994)

Diagnostic value of tumour markers in pleural effusions
por: Volarić, Darian, et al.
Publicado: (2018)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
por: Harding, M., et al.
Publicado: (1990)

The predictive value of immunohistochemical markers in untreated Wilms’ tumour: are they useful?
por: Ghanem, Mazen A., et al.
Publicado: (2011)

Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data.
por: Birch, J. M., et al.
Publicado: (1980)

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.
por: van der Gaast, A., et al.
Publicado: (1994)

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
por: Biesma, B., et al.
Publicado: (1992)

Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.
por: Thatcher, N., et al.
Publicado: (1985)

EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
por: Foy, Victoria, et al.
Publicado: (2021)

The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung
por: Strand, Trond-Eirik, et al.
Publicado: (2015)

Diagnostic value of HSP90α and related markers in lung cancer
por: Yuan, Zhimin, et al.
Publicado: (2022)

Tumour markers of prognosis in colorectal cancer
por: McLeod, H L, et al.
Publicado: (1999)

Serum biochemical markers in lung cancer.
por: Burt, R. W., et al.
Publicado: (1978)

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995)

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment
por: Bartsch, Rupert, et al.
Publicado: (2006)

Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
por: Yoon, Ho Il, et al.
Publicado: (2016)

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
por: Plebani, M., et al.
Publicado: (1995)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Assessing tumour markers.
por: Tate, H.
Publicado: (1981)

Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas.
por: Dias, P., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_eb19s872cn6pq0ah4l7p09inkm